Support Needs and Coping Strategies in Non-Alcoholic Fatty Liver Disease (NAFLD): A Multidisciplinary Approach to Potential Unmet Challenges beyond Pharmacological Treatment
Abstract
:1. Introduction
2. Methods
3. Awareness and Understanding of NAFLD
4. Fatigue and NAFLD
5. NAFLD and Mental Health
6. Perceived Stigmatisation
7. Loneliness and Social Isolation
8. A Compassionate Approach in the Context of NAFLD
9. Coping Strategies
10. Future Research Directions and Concluding Remarks
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Lazarus, J.V.; Colombo, M.; Cortez-Pinto, H.; Huang, T.T.; Miller, V.; Ninburg, M.; Schattenberg, J.M.; Seim, L.; Wong, V.W.S.; Zelber-Sagi, S. NAFLD—Sounding the alarm on a silent epidemic. Nat. Rev. Gastroenterol. Hepatol. 2020, 17, 377–379. [Google Scholar] [CrossRef] [PubMed]
- Younossi, Z.M.; Marchesini, G.; Pinto-Cortez, H.; Petta, S. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation. Transplantation 2019, 103, 22–27. [Google Scholar] [CrossRef] [PubMed]
- Estes, C.; Anstee, Q.M.; Arias-Loste, M.T.; Bantel, H.; Bellentani, S.; Caballeria, J.; Colombo, M.; Craxi, A.; Crespo, J.; Day, C.P.; et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030. J. Hepatol. 2018, 69, 896–904. [Google Scholar] [CrossRef]
- Rinaldi, L.; Pafundi, P.C.; Galiero, R.; Caturano, A.; Morone, M.V.; Silvestri, C.; Giordano, M.; Salvatore, T.; Sasso, F.C. Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review. Antioxidants 2021, 10, 270. [Google Scholar] [CrossRef] [PubMed]
- Godoy-Matos, A.F.; Silva Junior, W.S.; Valerio, C.M. NAFLD as a continuum: From obesity to metabolic syndrome and diabetes. Diabetol. Metab. Syndr 2020, 12, 60. [Google Scholar] [CrossRef]
- Kyrou, I.; Randeva, H.S.; Tsigos, C.; Kaltsas, G.; Weickert, M.O. Clinical Problems Caused by Obesity. In Endotext; Feingold, K.R., Anawalt, B., Boyce, A., Chrousos, G., de Herder, W.W., Dhatariya, K., Dungan, K., Hershman, J.M., Hofland, J., Kalra, S., et al., Eds.; MDText.com, Inc.: South Dartmouth, MA, USA, 2000. [Google Scholar]
- Hassen, G.; Singh, A.; Belete, G.; Jain, N.; De la Hoz, I.; Camacho-Leon, G.P.; Dargie, N.K.; Carrera, K.G.; Alemu, T.; Jhaveri, S.; et al. Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease. Cureus 2022, 14, e25495. [Google Scholar] [CrossRef]
- Kalpadakis, S.; Sifaki-Pistolla, D.; Symvoulakis, E.K.; Kelefiotis-Stratidakis, P.; Vamvakas, L.; Mavroudis, D.; Lionis, C. Reporting Liver Cancer Trends in the Island of Crete, Greece: Results from a Geo-Epidemiological Study. Int. J. Environ. Res. Public Health 2022, 19, 10166. [Google Scholar] [CrossRef]
- Karlsen, T.H.; Sheron, N.; Zelber-Sagi, S.; Carrieri, P.; Dusheiko, G.; Bugianesi, E.; Pryke, R.; Hutchinson, S.J.; Sangro, B.; Martin, N.K.; et al. The EASL-Lancet Liver Commission: Protecting the next generation of Europeans against liver disease complications and premature mortality. Lancet 2022, 399, 61–116. [Google Scholar] [CrossRef]
- Shea, S.; Lionis, C.; Kite, C.; Atkinson, L.; Chaggar, S.S.; Randeva, H.S.; Kyrou, I. Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress. Biomedicines 2021, 9, 1697. [Google Scholar] [CrossRef]
- Lazarus, J.V.; Kakalou, C.; Palayew, A.; Karamanidou, C.; Maramis, C.; Natsiavas, P.; Picchio, C.A.; Villota-Rivas, M.; Zelber-Sagi, S.; Carrieri, P. A Twitter discourse analysis of negative feelings and stigma related to NAFLD, NASH and obesity. Liver Int. 2021, 41, 2295–2307. [Google Scholar] [CrossRef]
- Alemany-Pages, M.; Moura-Ramos, M.; Araujo, S.; Macedo, M.P.; Ribeiro, R.T.; do, O.D.; Ramalho-Santos, J.; Azul, A.M. Insights from qualitative research on NAFLD awareness with a cohort of T2DM patients: Time to go public with insulin resistance? BMC Public Health 2020, 20, 1142. [Google Scholar] [CrossRef] [PubMed]
- Berry, P.; Kotha, S. The Challenging Ethical Landscape of Non-alcoholic Fatty Liver Disease. EMJ Hepatol. 2022. Available online: https://www.emjreviews.com/hepatology/article/the-challenging-ethical-landscape-of-non-alcoholic-fatty-liver-disease/#:~:text=Ethical%20dilemmas%20in%20the%20management,to%20discussing%20and%20managing%20obesity (accessed on 20 August 2022). [CrossRef]
- Campagne, D.M. Stress and perceived social isolation (loneliness). Arch. Gerontol. Geriatr. 2019, 82, 192–199. [Google Scholar] [CrossRef] [PubMed]
- Carol, M.; Perez-Guasch, M.; Sola, E.; Cervera, M.; Martinez, S.; Juanola, A.; Ma, A.T.; Avitabile, E.; Napoleone, L.; Pose, E.; et al. Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life. PLoS ONE 2022, 17, e0265153. [Google Scholar] [CrossRef]
- Francque, S.M.; Marchesini, G.; Kautz, A.; Walmsley, M.; Dorner, R.; Lazarus, J.V.; Zelber-Sagi, S.; Hallsworth, K.; Busetto, L.; Fruhbeck, G.; et al. Non-alcoholic fatty liver disease: A patient guideline. JHEP Rep. 2021, 3, 100322. [Google Scholar] [CrossRef]
- Cene, C.W.; Beckie, T.M.; Sims, M.; Suglia, S.F.; Aggarwal, B.; Moise, N.; Jimenez, M.C.; Gaye, B.; McCullough, L.D. Effects of Objective and Perceived Social Isolation on Cardiovascular and Brain Health: A Scientific Statement From the American Heart Association. J. Am. Heart Assoc. 2022, 11, e026493. [Google Scholar] [CrossRef]
- Ida, S.; Kaneko, R.; Imataka, K.; Okubo, K.; Shirakura, Y.; Azuma, K.; Fujiwara, R.; Takahashi, H.; Murata, K. Factors associated with social isolation and being homebound among older patients with diabetes: A cross-sectional study. BMJ Open 2020, 10, e037528. [Google Scholar] [CrossRef]
- Jung, F.U.; Luck-Sikorski, C. Overweight and Lonely? A Representative Study on Loneliness in Obese People and Its Determinants. Obes. Facts 2019, 12, 440–447. [Google Scholar] [CrossRef]
- Kim, K.; Jung, S.J.; Baek, J.M.; Yim, H.W.; Jeong, H.; Kim, D.J.; Park, S.; Youm, Y.; Kim, H.C. Associations between social network properties and metabolic syndrome and the mediating effect of physical activity: Findings from the Cardiovascular and Metabolic Diseases Etiology Research Center (CMERC) Cohort. BMJ Open Diabetes Res. Care 2020, 8, e001272. [Google Scholar] [CrossRef]
- Morrill, K.E.; Crocker, R.M.; Hingle, M.D.; Thomson, C.A.; Garcia, D.O. Awareness, Knowledge, and Misperceptions Related to Nonalcoholic Fatty Liver Disease in a Community Sample of Mexican-Origin Women: A Mixed Methods Study. Front Public Health 2021, 9, 626428. [Google Scholar] [CrossRef]
- Wieland, A.C.; Mettler, P.; McDermott, M.T.; Crane, L.A.; Cicutto, L.C.; Bambha, K.M. Low awareness of nonalcoholic fatty liver disease among patients at high metabolic risk. J. Clin. Gastroenterol. 2015, 49, e6–e10. [Google Scholar] [CrossRef] [PubMed]
- Tincopa, M.A.; Wong, J.; Fetters, M.; Lok, A.S. Patient disease knowledge, attitudes and behaviours related to non-alcoholic fatty liver disease: A qualitative study. BMJ Open Gastroenterol. 2021, 8, e000634. [Google Scholar] [CrossRef] [PubMed]
- Newton, J.L.; Jones, D.E.; Henderson, E.; Kane, L.; Wilton, K.; Burt, A.D.; Day, C.P. Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insuling resistance. Gut 2008, 57, 807–813. [Google Scholar] [CrossRef] [PubMed]
- Jung, J.Y.; Park, S.K.; Oh, C.M.; Chung, P.W.; Ryoo, J.H. Non-Alcoholic Fatty Liver Disease and Its Association with Depression in Korean General Population. J. Korean Med. Sci. 2019, 34, e199. [Google Scholar] [CrossRef] [PubMed]
- Youssef, N.A.; Abdelmalek, M.F.; Binks, M.; Guy, C.D.; Omenetti, A.; Smith, A.D.; Diehl, A.M.; Suzuki, A. Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease. Liver Int. 2013, 33, 1062–1070. [Google Scholar] [CrossRef]
- Weinstein, A.A.; Kallman Price, J.; Stepanova, M.; Poms, L.W.; Fang, Y.; Moon, J.; Nader, F.; Younossi, Z.M. Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C. Psychosomatics 2011, 52, 127–132. [Google Scholar] [CrossRef]
- Kim, D.; Yoo, E.R.; Li, A.A.; Tighe, S.P.; Cholankeril, G.; Harrison, S.A.; Ahmed, A. Depression is associated with non-alcoholic fatty liver disease among adults in the United States. Aliment. Pharmacol. Ther. 2019, 50, 590–598. [Google Scholar] [CrossRef]
- Choi, J.M.; Chung, G.E.; Kang, S.J.; Kwak, M.S.; Yang, J.I.; Park, B.; Yim, J.Y. Association Between Anxiety and Depression and Nonalcoholic Fatty Liver Disease. Front. Med. 2020, 7, 585618. [Google Scholar] [CrossRef]
- Han, A.L. Association between Non-Alcoholic Fatty Liver Disease and Dietary Habits, Stress, and Health-Related Quality of Life in Korean Adults. Nutrients 2020, 12, 1555. [Google Scholar] [CrossRef]
- Kang, D.; Zhao, D.; Ryu, S.; Guallar, E.; Cho, J.; Lazo, M.; Shin, H.; Chang, Y.; Sung, E. Perceived stress and non-alcoholic fatty liver disease in apparently healthy men and women. Sci. Rep. 2020, 10, 38. [Google Scholar] [CrossRef]
- Li, C.; Xing, J.J.; Shan, A.Q.; Leng, L.; Liu, J.C.; Yue, S.; Yu, H.; Chen, X.; Tian, F.S.; Tang, N.J. Increased risk of nonalcoholic fatty liver disease with occupational stress in Chinese policemen: A 4-year cohort study. Medicine 2016, 95, e5359. [Google Scholar] [CrossRef] [PubMed]
- Henriksen, R.E.; Nilsen, R.M.; Strandberg, R.B. Loneliness as a risk factor for metabolic syndrome: Results from the HUNT study. J. Epidemiol. Community Health 2019, 73, 941–946. [Google Scholar] [CrossRef]
- Brinkhues, S.; Dukers-Muijrers, N.; Hoebe, C.; van der Kallen, C.J.H.; Dagnelie, P.C.; Koster, A.; Henry, R.M.A.; Sep, S.J.S.; Schaper, N.C.; Stehouwer, C.D.A.; et al. Socially isolated individuals are more prone to have newly diagnosed and prevalent type 2 diabetes mellitus—The Maastricht study. BMC Public Health 2017, 17, 955. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Valtorta, N.K.; Kanaan, M.; Gilbody, S.; Ronzi, S.; Hanratty, B. Loneliness and social isolation as risk factors for coronary heart disease and stroke: Systematic review and meta-analysis of longitudinal observational studies. Heart 2016, 102, 1009–1016. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Brenton-Peters, J.; Consedine, N.S.; Boggiss, A.; Wallace-Boyd, K.; Roy, R.; Serlachius, A. Self-compassion in weight management: A systematic review. J. Psychosom. Res. 2021, 150, 110617. [Google Scholar] [CrossRef] [PubMed]
- Austin, J.; Drossaert, C.H.C.; Schroevers, M.J.; Sanderman, R.; Kirby, J.N.; Bohlmeijer, E.T. Compassion-based interventions for people with long-term physical conditions: A mixed methods systematic review. Psychol. Health 2021, 36, 16–42. [Google Scholar] [CrossRef] [PubMed]
- Ramalho, T.; Pereira, J.; Ferreira, C. How Compassionate Abilities Influence the Experience of Loneliness and Quality of Life of People with and without Chronic Physical Disease? J. Psychol. 2021, 155, 679–694. [Google Scholar] [CrossRef]
- Funuyet-Salas, J.; Perez-San-Gregorio, M.A.; Martin-Rodriguez, A.; Romero-Gomez, M. Quality of Life and Coping in Nonalcoholic Fatty Liver Disease: Influence of Diabetes and Obesity. Int. J. Environ. Res. Public Health 2021, 18, 3503. [Google Scholar] [CrossRef]
- Yasmeen, B.; Khan, M.Z.; Jamshaid, N.; Salman, M. Coping strategies during chronic illness; a comparative study of cardiac and renal failure patients. Professional. Med. J. 2015, 22, 483–489. [Google Scholar] [CrossRef]
- Raposa, E.B.; Laws, H.B.; Ansell, E.B. Prosocial Behavior Mitigates the Negative Effects of Stress in Everyday Life. Clin. Psychol. Sci. 2016, 4, 691–698. [Google Scholar] [CrossRef]
- Lazar, L.; Eisenberger, N.I. The benefits of giving: Effects of prosocial behavior on recovery from stress. Psychophysiology 2022, 59, e13954. [Google Scholar] [CrossRef] [PubMed]
- Ayonrinde, O.T. Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD—Reconciling the present with the past. JHEP Rep. 2021, 3, 100261. [Google Scholar] [CrossRef] [PubMed]
- Lonardo, A. Back to the future: From the history of NAFLD to MAFLD to heterogeneity of disease. Clin. Transl. Discov. 2021, 1, e9. [Google Scholar] [CrossRef]
- Eslam, M.; Sanyal, A.J.; George, J.; International Consensus Panel. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology 2020, 158, 1999–2014.e1. [Google Scholar] [CrossRef] [PubMed]
- Fouad, Y.; Waked, I.; Bollipo, S.; Gomaa, A.; Ajlouni, Y.; Attia, D. What’s in a name? Renaming ‘NAFLD’ to ‘MAFLD’. Liver Int. 2020, 40, 1254–1261. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shiha, G.; Korenjak, M.; Eskridge, W.; Casanovas, T.; Velez-Moller, P.; Hogstrom, S.; Richardson, B.; Munoz, C.; Sigurethardottir, S.; Coulibaly, A.; et al. Redefining fatty liver disease: An international patient perspective. Lancet Gastroenterol. Hepatol. 2021, 6, 73–79. [Google Scholar] [CrossRef] [PubMed]
- Golabi, P.; Otgonsuren, M.; Cable, R.; Felix, S.; Koenig, A.; Sayiner, M.; Younossi, Z.M. Non-alcoholic Fatty Liver Disease (NAFLD) is associated with impairment of Health Related Quality of Life (HRQOL). Health Qual. Life Outcomes 2016, 14, 18. [Google Scholar] [CrossRef] [Green Version]
- Gerber, L.H.; Weinstein, A.A.; Mehta, R.; Younossi, Z.M. Importance of fatigue and its measurement in chronic liver disease. World J. Gastroenterol. 2019, 25, 3669–3683. [Google Scholar] [CrossRef]
- Swain, M.G.; Jones, D.E.J. Fatigue in chronic liver disease: New insights and therapeutic approaches. Liver Int. 2019, 39, 6–19. [Google Scholar] [CrossRef] [Green Version]
- GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018, 392, 1789–1858. [Google Scholar] [CrossRef]
- Kyrou, I.; Kollia, N.; Panagiotakos, D.; Georgousopoulou, E.; Chrysohoou, C.; Tsigos, C.; Randeva, H.S.; Yannakoulia, M.; Stefanadis, C.; Papageorgiou, C.; et al. Association of depression and anxiety status with 10-year cardiovascular disease incidence among apparently healthy Greek adults: The ATTICA Study. Eur. J. Prev. Cardiol. 2017, 24, 145–152. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kyrou, I.; Randeva, H.S.; Tsigos, C. Stress, Insulin Resistance and Type II Diabetes; Academic Press: San Diego, CA, USA, 2017. [Google Scholar]
- Radford-Smith, D.E.; Patel, P.J.; Irvine, K.M.; Russell, A.; Siskind, D.; Anthony, D.C.; Powell, E.E.; Probert, F. Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism. PLoS ONE 2022, 17, e0261555. [Google Scholar] [CrossRef] [PubMed]
- Osborne, M.T.; Shin, L.M.; Mehta, N.N.; Pitman, R.K.; Fayad, Z.A.; Tawakol, A. Disentangling the Links Between Psychosocial Stress and Cardiovascular Disease. Circ. Cardiovasc. Imaging 2020, 13, e010931. [Google Scholar] [CrossRef] [PubMed]
- Tsigos, C.; Kyrou, I.; Kassi, E.; Chrousos, G.P. Stress: Endocrine Physiology and Pathophysiology. In Endotext; Feingold, K.R., Anawalt, B., Boyce, A., Chrousos, G., de Herder, W.W., Dhatariya, K., Dungan, K., Hershman, J.M., Hofland, J., Kalra, S., et al., Eds.; MDText.com, Inc.: South Dartmouth, MA, USA, 2000. [Google Scholar]
- Lazarus, J.V.; Mark, H.E.; Anstee, Q.M.; Arab, J.P.; Batterham, R.L.; Castera, L.; Cortez-Pinto, H.; Crespo, J.; Cusi, K.; Dirac, M.A.; et al. Advancing the global public health agenda for NAFLD: A consensus statement. Nat. Rev. Gastroenterol. Hepatol. 2022, 19, 60–78. [Google Scholar] [CrossRef] [PubMed]
- Hu, T.; Zheng, X.; Huang, M. Absence and Presence of Human Interaction: The Relationship Between Loneliness and Empathy. Front Psychol. 2020, 11, 768. [Google Scholar] [CrossRef] [PubMed]
- Xia, N.; Li, H. Loneliness, Social Isolation, and Cardiovascular Health. Antioxid. Redox Signal. 2018, 28, 837–851. [Google Scholar] [CrossRef] [Green Version]
- Jovicic, A.; McPherson, S. To support and not to cure: General practitioner management of loneliness. Health Soc. Care Community 2020, 28, 376–384. [Google Scholar] [CrossRef] [PubMed]
- Kharicha, K.; Iliffe, S.; Manthorpe, J.; Chew-Graham, C.A.; Cattan, M.; Goodman, C.; Kirby-Barr, M.; Whitehouse, J.H.; Walters, K. What do older people experiencing loneliness think about primary care or community based interventions to reduce loneliness? A qualitative study in England. Health Soc. Care Community 2017, 25, 1733–1742. [Google Scholar] [CrossRef] [Green Version]
- WHO. Social Isolation and Loneliness. Available online: https://www.who.int/teams/social-determinants-of-health/demographic-change-and-healthy-ageing/social-isolation-and-loneliness (accessed on 15 August 2022).
- Shea, S.; Lionis, C. Compassionate Care within the Primary Health Care Setting: Before and During a Public Health Crisis. In The Art and Science of Compassionate Care: A Practical Guide; Samoutis, A., Ed.; Springer: Berlin/Heidelberg, Germany, In Press.
- Martin, J.C.; Hartley, S.L. Lonely, Stressed, and Depressed: The Impact of Isolation on U.S. Veterans. Mil. Behav. Health 2017, 5, 384–392. [Google Scholar] [CrossRef]
- Cuevas, A.G.; Chen, R.; Thurber, K.A.; Slopen, N.; Williams, D.R. Psychosocial Stress and Overweight and Obesity: Findings From the Chicago Community Adult Health Study. Ann. Behav. Med. 2019, 53, NP. [Google Scholar] [CrossRef]
- Kivimaki, M.; Steptoe, A. Effects of stress on the development and progression of cardiovascular disease. Nat. Rev. Cardiol. 2018, 15, 215–229. [Google Scholar] [CrossRef] [PubMed]
- Lian, Y.; Sun, Q.; Guan, S.; Ge, H.; Tao, N.; Jiang, Y.; Zhang, Y.; Ning, L.; Xiao, J.; Liu, J. Effect of Changing Work Stressors and Coping Resources on the Risk of Type 2 Diabetes: The OHSPIW Cohort Study. Diabetes Care 2018, 41, 453–460. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Goetz, J.L.; Keltner, D.; Simon-Thomas, E. Compassion: An evolutionary analysis and empirical review. Psychol. Bull. 2010, 136, 351–374. [Google Scholar] [CrossRef] [Green Version]
- Shea, S.; Lionis, C. Compassion in healthcare. In The Oxford Handbook of Compassion Science; Seppala, E., Simon-Thomas, E., Brown, S.L., Worline, M.C., Cameron, D.D., Doty, J.R., Eds.; Oxford University Press: New York, NY, USA, 2017; pp. 457–475. [Google Scholar]
- Fogarty, L.A.; Curbow, B.A.; Wingard, J.R.; McDonnell, K.; Summerfield, M.R. Can 40 seconds of compassion reduce patient anxiety? J. Clin. Oncol. 1999, 17, 371. [Google Scholar] [CrossRef] [Green Version]
- Shaltout, H.A.; Tooze, J.A.; Rosenberger, E.; Kemper, K.J. Time, touch, and compassion: Effects on autonomic nervous system and well-being. Explore 2012, 8, 177–184. [Google Scholar] [CrossRef] [PubMed]
- Youngson, R. Time to Care: How to Love Your Patients and Your Job; Rebelheart Publishers: Raglan, New Zealand, 2012. [Google Scholar]
- Reynolds, R.; Dennis, S.; Hasan, I.; Slewa, J.; Chen, W.; Tian, D.; Bobba, S.; Zwar, N. A systematic review of chronic disease management interventions in primary care. BMC Fam. Pract 2018, 19, 11. [Google Scholar] [CrossRef]
- de Zulueta, P. Touch matters: COVID-19, physical examination, and 21st century general practice. Br. J. Gen. Pract 2020, 70, 594–595. [Google Scholar] [CrossRef]
- Hunt, C.M.; Turner, M.J.; Gifford, E.J.; Britt, R.B.; Su, G.L. Identifying and Treating Nonalcoholic Fatty Liver Disease. Fed Pract 2019, 36, 20–29. [Google Scholar]
- Strom, J.L.; Egede, L.E. The impact of social support on outcomes in adult patients with type 2 diabetes: A systematic review. Curr. Diab. Rep. 2012, 12, 769–781. [Google Scholar] [CrossRef]
Study [Reference] | Country | Study Design/Cohort | Concept | Outcome/Main Findings |
---|---|---|---|---|
Alemany-Pages et al. (2020) [12] | Portugal | Cross-sectional N = 30 (53% female) Median Age: 65 | Awareness | Low awareness of NAFLD both as a disease entity, and in terms of its progression to end-stage liver disease or its association with other metabolic conditions. |
Morill et al. (2021) [21] | Mexico | Mixed methods: Cross-sectional N = 194 (100% female) Median Age: 47 Semi-structured interviews N = 26 (100% female) | Awareness | Low awareness of risk factors for liver disease. Knowledge regarding liver disease was mainly centered on cirrhosis. The findings from both the quantitative and qualitative study identified that sources of information for NAFLD were mainly friends, family, and media. Interviews revealed a misperception related to NAFLD risk, namely that liver disease was only caused by high alcohol intake. |
Wieland et al. (2015) [22] | USA | Self-administered questionnaire N = 302 | Awareness | Low awareness of NAFLD among individuals at high metabolic risk. Most paticipants reported interest in learning more about NAFLD. |
Tincopa et al. (2021) [23] | USA | Qualitative N = 29 (51.7% female) Age: 51.7% ≥50 years | Awareness | Patients showed awareness of lifestyle interventions as the main therapy for NAFLD, but expressed a gap in knowledge regarding the condition. The presence of social support and competing medical comorbidities were the most consistent facilitators and barriers to lifestyle change. |
Newton et al. (2008) [24] | UK | Cohort study N = 120 (57% male) Mean Age: 53 | Fatigue | Fatigue is a significant problem in NAFLD, and is associated with impaired physical function. Fatigue among patients with NAFLD does not seem to be related to either the severity of underlying liver disease or insulin resistance. |
Jung et al. (2019) [25] | Korea | Observational N = 112,797 (51.5% female) Mean Age: 40 | Depression and Anxiety | Both the presence and severity of NAFLD are significantly associated with symptoms of depression. |
Youssef et al. (2013) [26] | USA | Cross-sectional N = 567 (67% female) Mean Age: 48 | Depression and Anxiety | Symptoms of depression and anxiety are common in patients with NAFLD. |
Weinstein et al. (2011) [27] | USA | Retrospective Patients with NAFLD: N = 184 (69.4% female) Mean Age: 46.7 | Depression and Anxiety | Higher prevalence of depression in patients with NAFLD and hepatitis C, compared with patients with hepatitis B and members of the general population. |
Kim et al. (2019) [28] | USA | Cross-sectional N = 10,484 (female: 51.2%) Mean Age: 47 | Depression and Anxiety | Higher prevalence of depression among individuals with NAFLD compared to those without. |
Choi et al. (2021) [29] | South Korea | Retrospective Cross-Sectional N = 25,333 (56.2% male) Mean Age: 47 | Depression and Anxiety | Severe steatosis is significantly related to both state and trait anxiety in patients with NAFLD. |
Han (2020) [30] | Korea | Cross-Sectional N = 17,726 (50.6% male) Mean Age: 43.9 | Stress | An indication of an increased risk of NAFLD (by 1.3 times) in individuals with increased perceived stress was identified. |
Kang et al. (2020) [31] | Korea | Cross-sectional N = 171,321 (50.1% male) | Stress | Independent association between higher levels of perceived stress and a greater prevalence of NAFLD. |
Li et al. (2016) [32] | China | Cross-sectional N = 2367 (100% male) Mean Age: 36.65 | Stress | High occupational stress and high personal strain identified as independent risk factors for NAFLD. |
Carol et al. (2022) [15] | Spain | Cross-sectional N = 144 (52% male) Mean Age: 64 | Perceived Stigma | Perceived stigmatisation is common among patients with NAFLD. This is independent of disease stage, and is associated with impaired quality of life. |
Lazarus et al. (2021) [11] | Global | Based on retrieval of tweets globablly: 16,835 tweets for NAFLD 2376 tweets for non-alcoholic steatohepatitis (NASH) | Pereived Stigma | Retrieved tweets mostly indicated an unmet information need, without any clear signs of stigma. However, the negative content of obesity tweets was recurrent. |
Kim et al. (2020) [20] | Korea | Cross-sectional Community based population: N = 8097 (66.6% female) Age range: 30–64 years Hospital based population: N = 2006 (58% male) Age range: 30–80 years (To avoid possible confounding effects from age differences, 1861 participants aged 65 years and older were excluded from final analyses). | Loneliness | Smaller social networks are associated with metabolic syndrome which could be partly due physical inactivity. |
Henriksen et al. (2019) [33] | Norway | Longitudinal N = 26,990 (55% female) Mean Age: 45 | Loneliness | Loneliness may be an important factor associated with an increased the risk for metabolic syndrome. The effect of loneliness on metabolic syndrome is mediated via depressive symptoms. |
Jung & Sikorski (2019) [19] | Germany | Cross-sectional N = 1000 (55.2% male) Mean Age: 56.4 | Loneliness | Greater levels of loneliness were reported by respondents with higher levels of depression, higher internalized weight bias, and experience of discrimination. |
Ida et al. (2020) [18] | Japan | Cross-sectional N = 558 (57.3% male) Mean Age: 73 | Loneliness | Glycaemic fluctuations and insulin use are associated with social isolation and being homebound among older patients with diabetes. |
Brinkues et al. (2017) [34] | Netherlands | Population-based cohort study N = 2861 (51% male) Mean Age: 60 | Loneliness | Several aspects of structural and functional characteristics of the social network are associated with newly and previously diagnosed type 2 diabetes. |
Valtorta et al. (2016) [35] | UK | Systematic Review | Loneliness | Findings suggest that deficiencies in social relationships are associated with an increased risk of developing coronary heart disease and stroke. |
Cene et al. (2022) [17] [36] | USA | Systematic Review | Loneliness | Evidence is most consistent for a direct association between social isolation, loneliness, and coronary heart disease and stroke mortality. |
Brenton-Peters et al. (2021) [36] | New Zealand | Systematic Review | Compassion | Self-compassion interventions tailored to weight management outcomes demonstrate efficacy with increasing self-compassion post-intervention. |
Austin et al. (2021) [37] | Netherlands | Systematic Review | Compassion | Feasibility and acceptability of compassion-based interventions among individuals with chronic conditions were rated high by participants. The review also revealed reduced anxiety and depression. Participants also indicated greater acceptance of their condition, reductions in feelings of loneliness, and improvements in emotion regulation skills. |
Ramalho et al. (2021) [38] | Portugal | Cross-sectional Participants with chronic disease: N = 278 (85.6% female) Mean Age: 42.20 | Compassion | Results highlight the crucial role of self-compassion skills and the ability to perceive others as compassionate, in loneliness and quality of life. This finding applies to individuals either with or without a chronic condition. |
Funuyet-Salas et al. (2021) [39] | Spain | Cross-sectional N = 307 (60.7% male) Mean Age: 54.8 | Coping | Diabetes and obesity were associated with lower quality of life in patients with NAFLD. Obesity was also associated with more passive/avoidance coping. Such strategies predicted lower quality of life than active strategies. |
Yasmeen et al. (2015) [40] | Pakistan | Qualitative Study N = 275 (66.9% males) Mean Age: 44 | Coping | Significant differences in the coping strategies utilised by cardiac and renal failure patients were identified. Renal failure patients used physical coping strategies more, whereas cardiac patients were more likely to use psychological and behavioral coping strategies |
Raposa et al. (2016) [41] | USA | Cross-sectional N = 77 (53.2% female) Mean Age: 24.52 | Coping | Prosocial behaviour moderates the effects of stress on positive affect, negative affect, and overall mental health, suggesting that helping behaviour could represent an important method for coping with stress. |
Lazar & Eisenberger 2022) [42] | Cross-sectional N = 91 (60.4% females) Mean Age: 20.84 | Coping | Findings demonstrate that engagement in prosocial behaviour following a stressor can help to downregulate physiological stress responses. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Shea, S.; Lionis, C.; Atkinson, L.; Kite, C.; Lagojda, L.; Chaggar, S.S.; Kyrou, I.; Randeva, H.S. Support Needs and Coping Strategies in Non-Alcoholic Fatty Liver Disease (NAFLD): A Multidisciplinary Approach to Potential Unmet Challenges beyond Pharmacological Treatment. Livers 2023, 3, 1-20. https://doi.org/10.3390/livers3010001
Shea S, Lionis C, Atkinson L, Kite C, Lagojda L, Chaggar SS, Kyrou I, Randeva HS. Support Needs and Coping Strategies in Non-Alcoholic Fatty Liver Disease (NAFLD): A Multidisciplinary Approach to Potential Unmet Challenges beyond Pharmacological Treatment. Livers. 2023; 3(1):1-20. https://doi.org/10.3390/livers3010001
Chicago/Turabian StyleShea, Sue, Christos Lionis, Lou Atkinson, Chris Kite, Lukasz Lagojda, Surinderjeet S. Chaggar, Ioannis Kyrou, and Harpal S. Randeva. 2023. "Support Needs and Coping Strategies in Non-Alcoholic Fatty Liver Disease (NAFLD): A Multidisciplinary Approach to Potential Unmet Challenges beyond Pharmacological Treatment" Livers 3, no. 1: 1-20. https://doi.org/10.3390/livers3010001
APA StyleShea, S., Lionis, C., Atkinson, L., Kite, C., Lagojda, L., Chaggar, S. S., Kyrou, I., & Randeva, H. S. (2023). Support Needs and Coping Strategies in Non-Alcoholic Fatty Liver Disease (NAFLD): A Multidisciplinary Approach to Potential Unmet Challenges beyond Pharmacological Treatment. Livers, 3(1), 1-20. https://doi.org/10.3390/livers3010001